Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
2
×
detroit top stories
fda
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
2
×
wisconsin blog main
wisconsin top stories
accent therapeutics
aducanumab
alder biopharmaceuticals
alzheimer's disease
amblyotech
amgen
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
brainvectis
What
fda
2
×
medicines
2
×
new
activity
amgen
approval
approvals
bio
biogen
candidates
clamped
class
covid
delays
developed
developing
drug
economic
fast
gets
head
including
ipo
isn’t
lot
migraine
nod
oric’s
pain
preventive
roundup
showing
spread
starts
testing
won
work
Language
unset
Current search:
fda
×
biotech
×
medicines
×
fda
×
" detroit blog main "
×
" texas top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines